Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes

Diabet Med. 2021 Jan;38(1):e14378. doi: 10.1111/dme.14378. Epub 2020 Sep 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 / epidemiology
  • COVID-19 Drug Treatment*
  • Comorbidity
  • Dexamethasone / administration & dosage*
  • Dexamethasone / adverse effects
  • Diabetes Mellitus / drug therapy*
  • Diabetes Mellitus / epidemiology*
  • Glycemic Control / methods*
  • Humans
  • Hypoglycemia / chemically induced
  • Hypoglycemia / prevention & control
  • Insulin, Isophane / administration & dosage
  • SARS-CoV-2*

Substances

  • Insulin, Isophane
  • Dexamethasone